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Abstract
Background: Detecting avian influenza virus has become an important public health strategy for controlling the
emerging infectious disease.
Methods: The HIS (hospital information system) modified influenza surveillance system (ISS) and a newly built
pneumonia surveillance system (PSS) were used to monitor the influenza viruses in Changsha City, China. The ISS
was used to monitor outpatients in two sentinel hospitals and to detect mild influenza and avian influenza cases,
and PSS was used to monitor inpatients in 49 hospitals and to detect severe and death influenza cases.
Results: From 2005 to 2016, there were 3,551,917 outpatients monitored by the ISS system, among whom 126,076
were influenza-like illness (ILI) cases, with the ILI proportion (ILI%) of 3.55%. After the HIS was used, the reported
incident cases of ILI and ILI% were increased significantly. From March, 2009 to September, 2016, there were 5,491,
560 inpatient cases monitored by the PSS system, among which 362,743 were pneumonia cases, with a proportion
of 6.61%. Among pneumonia cases, about 10.55% (38,260/362,743) of cases were severe or death cases. The
pneumonia incidence increased each year in the city. Among 15 avian influenza cases reported from January, 2005
to September, 2016, there were 26.7% (4/15) mild cases detected by the HIS-modified ISS system, while 60.0% (9/
15) were severe or death cases detected by the PSS system. Two H5N1 severe cases were missed by the ISS system
in January, 2009 when the PSS system was not available.
Conclusions: The HIS was able to improve the efficiency of the ISS for monitoring ILI and emerging avian influenza
virus. However, the efficiency of the system needs to be verified in a wider area for a longer time span in China.
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Background
In recent years, reports about human cases of infected
emerging avian influenza virus has become more and more
common [1–4]. Human infected H5N1 virus was first
reported in 1997 in Hong Kong, China, and then was
spread widely in mainland China [5] as well as many other
countries in Southeast Asia [6, 7], West Asia [8, 9], and Af-
rica [10]. Thereafter, human cases infected with emerging
influenza viruses were reported in the subsequent years, es-
pecially in China. For example, H7N9 was reported in 2013
[11], H5N6 in 2014 [2, 12–15], H10N8 in 2013 [1], and
H9N2 in 2013 in Hunan province, China [16]. It is import-
ant to detect these emerging viruses in and out of China.
There are currently two main surveillance systems fo-
cused on detecting / monitoring the virus in China. One is
China’s national sentinel surveillance system for influenza-
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like illness (ILI) in sentinel hospitals across 31 provinces in
mainland China. The sentinel hospitals are accounted for
2.5% of all hospitals in China [17]. The other one is the na-
tional pneumonia surveillance system, which was built by
the Chinese Center for Disease Control and Prevention
(CDC) in 2004. The system is mainly to monitor pneumo-
nia of unknown etiology (PUE) to facilitate timely detection
of novel respiratory pathogens, such as severe acute re-
spiratory syndrome (SARS) and avian influenza [18]. The
two systems have played significant roles in monitoring the
activity of influenza, controlling and preventing emerging
avian influenza [17–19].
Traditionally, the number of ILI cases was counted
manually by influenza surveillance staff. Therefore, the
hospital information system (HIS) has been used for re-
cording and monitoring the outpatients in most hospi-
tals in China [20, 21]. The PUE surveillance system was
not (and is still not) used consistently because most
cases on community-acquired pneumonia met the PUE
criteria, but were not reported to the PUE system [18].
The PUE surveillance system was not sensitive enough
to detect the emerging avian influenza virus.
To explore a new way to monitor influenza virus by
using HIS and improve the sensitivity of detecting emer-
ging avian influenza virus, we modified the influenza
surveillance system (ISS) and built a pneumonia surveil-
lance system (PSS) in Changsha City, China. In this
study, we separately reported the roles of the ISS and
the PSS systems in detecting influenza and emerging
avian influenza virus.
Methods
Study area
Changsha (27°51′~ 28°41′ N, 111°53′~ 114°15′ E), a large
city with 7.04 million people in central south China, is the
capital of Hunan Province. It includes 6 districts, 2 coun-
ties, and 1 county-level city. There are a total of 4586 hos-
pitals, clinics, and public health departments all over the
city. In this study, there were 49 secondary and tertiary
hospitals included into the PSS system and 2 tertiary hos-
pitals into the ISS system, respectively. The two hospitals
in ISS system were also included in the PSS. The locations
of the selected hospitals were shown in Fig. 1.
The modified influenza surveillance system
The ISS, based on two sentinel hospitals (hospitals A
and B), was set up in Changsha in September 2005. Hos-
pital A, which is located in the south urban area of the
city, is a tertiary hospital with more than 2700 staffs and
1839 hospital beds. Hospital B, which is located in the
north urban area of the city, is also a tertiary hospital
with more than 1700 staffs and 1593 hospital beds. Both
hospitals have the administrative department that is in
charge of the routine surveillance. Hospital A is a
municipally designated hospital for the diagnosis and
treatment of tuberculosis.
In 2006 and 2008, the ISS system became a branch of
Hunan provincial and national influenza surveillance net-
work respectively. In February, 2012, the HIS was adopted
for the surveillance in hospital A, and was modified after
June, 2013. The ISS in Changsha underwent five stages
(stage 1: week 39, 2005 to week 52, 2005; stage 2: week 1,
2006 to week 52, 2007; stage 3: week 1, 2008 to week 5,
2012; stage 4: week 6, 2012 to week 24, 2013; stage 5: week
25, 2013 to week 41, 2016.). During stage 1 to 3, the two
sentinel hospitals registered ILI cases manually in five out-
patient departments, including outpatient and emergency
departments of respiratory medicine, outpatient and
emergency departments of pediatrics, and fever clinic.
During stage 4 to 5, hospital B remained the manual sur-
veillance in the same outpatient departments. ILI case was
defined as “fever (axillary temperature ≥ 38°C) + cough or
sore throat” [22, 23].
Differently, in hospital A, HIS was adopted into the
ISS during stage 4 to 5 and was also named as “HIS
(stage 1)” and “HIS (stage 2)” respectively. During stage
4, all outpatient departments of the hospital were in-
cluded in the ISS, and the computer would emerge a
popup window by HIS with the question that “ILI or
not” if physicians diagnosed one of the 108 influenza-
associated diseases based on the International Classifica-
tion of Diseases 10th Revision (ICD-10). The physician
should answer the question to continue the later part to
treat the diseases from the patients. But we found that
some ILI cases could still be missed probably because of
the misunderstanding of the definition of ILI of the
physician, especially if the physician was not in the de-
partment with the ISS system during stage 1 to 3. There-
fore, during stage 5, the question was changed to three
options: a) fever (axillary temperature ≥ 38 °C), b) cough,
c) sore throat. The procedure of HIS would count the
ILI automatically by computing the number of “a) + b)”,
“a) + c)”, and “a) + b) + c)”.
During the 5 stages, the patients who visited the out-
patient departments of the two hospitals and were iden-
tified as potential ILI cases, were calculated every week.
At least 5–20 throat swab samples of ILI cases per hos-
pital per week were collected for testing the influenza
virus by reverse transcription polymerase chain reaction
(RT-PCR) and / or cell culture in the laboratory of
Changsha CDC. The criteria for including ILI patients
who were chosen to collect the samples were: a) the pa-
tients were in three days after illness onset date; b) the
patients had no history of using antivirals. These sample
selection and laboratory surveillance procedures were
based on the National Influenza Surveillance Program
(2010 edition and 2017 edition) which was announced
by the National Health Commission of the People’s
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Republic of China. This system may monitor influenza
and emerging avian influenza cases with mild symptoms
or at the early stage of the infection (Fig. 2). Data of the
system from week 39, 2005 to week 41, 2016 were col-
lected in our study. Because H1N1pdm was firstly
emerged in 2009 [24, 25], the virus was not tested in ISS
stages 1 and 2 (Table 1).
The new pneumonia surveillance system
The PSS was built in Changsha in March, 2009.
Pneumonia related inpatient departments in all 49
hospitals (excluding the primary health care centers
and private clinics) in Changsha were enrolled into
the system. This system monitors pneumonia cases
among inpatient population. The public health staff in
the surveillance hospitals would count the total num-
ber of monitored inpatients, pneumonia cases, severe
or death pneumonia cases diagnosed by physicians
and then they reported to CDC monthly. When cases
were suspected as infected with avian influenza virus
by clinicians, the throat swab or lower respiratory
tract samples of the suspicious patients (either pneu-
monia cases, severe or death pneumonia cases) were
collected for testing the virus by RT-PCR in the la-
boratory of Changsha CDC. All the surveillance pro-
cedures were performed in every month of each year.
However, because H5N6 was first emerged in 2014
and H7N9 in 2013 in China [2, 12, 15, 17], the
viruses were not tested from ISS stage 1 to 4, and
from ISS stage 1 to 3, respectively (Table 1). The PSS
system may monitor influenza and emerging avian in-
fluenza cases with severe symptoms or death (Fig. 2).
In this study, we collected the data of the system
from March, 2009 to September, 2016.
Statistical methods
The sentinel hospitals A and B are located in the south
and north in the same city. We assumed that the outpa-
tients were from the same age group. Therefore, three
indicators (d1, d2 and d3) were used to compare the dif-
ference between the two hospitals among the five stages.
They were the differences of weekly number of moni-
tored outpatients, ILI, and ILI% of the two hospitals, and
were expressed as follows:
d1 ¼ xA  xB
d2 ¼ yA  yB
d3 ¼ zA  zB
xA, xB, yA, yB, zA and zB refer to weekly number of
monitored outpatients of hospital A, weekly number of
monitored outpatients of hospital B, weekly ILI of hos-
pital A, weekly ILI of hospital B, weekly ILI% of hospital
A, and weekly ILI% of hospital B.
Fig. 1 Locations of 49 hospitals in pneumonia surveillance system and 2 hospitals influenza surveillance system in Changsha City, China. The map
depicted in this figure was taken from Wikimedia Commons (http://commons.wikimedia.org/wiki/Main_Page). PSS, pneumonia surveillance
system; ISS, influenza surveillance system
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The Analysis of variance (ANOVA) was employed
to show the d1, d2 and d3 among the five surveillance
stages of the two sentinel hospitals. If there is a stat-
istical significance, the Least Significant Difference
(LSD) method will be adopted to conduct the mul-
tiple comparisons between any two stages. P < 0.05
was considered statistically significant.
Results
Influenza surveillance system
From week 39 (from 26th September to 2nd October) in
2005 to week 41 (from10th October to 16th October) in
2016, a total of 3,551,917 outpatients were monitored by
the ISS system, among whom 126,076 were ILI cases,
with the ILI% of 3.55% (Table 1). From the two sentinel
Fig. 2 Flowchart of detecting influenza and avian influenza virus by influenza surveillance system and pneumonia surveillance system in
Changsha City, China. PSS, pneumonia surveillance system; ISS, influenza surveillance system; ILI, influenza-like illness; PCR, polymerase
chain reaction
Table 1 Outcomes during different surveilled stages of influenza surveillance system in Changsha City, China
Sentinel
hospitals
Stages Surveilled
patients
ILI ILI% Number
of tested
specimens
Number of positive
H3N2 H1N1 H1N1pdm A (untyped) B H5N1 H5N6 H7N9 H9N2 Total
Hospital A 1 8203 188 2.29 30 0 1 NA 0 0 0 NA NA 0 1
2 123,731 2100 1.70 721 53 20 NA 0 8 0 NA NA 0 81
3 503,835 17,190 3.41 2692 47 31 188 59 64 0 NA NA 0 389
4 379,441 10,014 2.64 641 41 0 31 0 12 0 NA 1 0 85
5 1,163,601 66,779 5.74 3534 178 0 124 1 202 0 1 0 2 508
Total 2,178,811 96,271 4.42 7618 319 52 343 60 286 0 1 1 2 1064
Hospital B 1 7754 452 5.83 29 0 1 NA 0 0 0 NA NA 0 1
2 177,460 2089 1.18 596 50 30 NA 0 1 0 NA NA 0 81
3 479,086 13,045 2.72 2626 58 52 171 46 73 0 NA NA 0 400
4 174,345 2382 1.37 651 43 0 30 0 8 0 NA 0 0 81
5 534,461 11,837 2.21 3393 151 0 66 0 172 0 0 0 0 389
Total 1,373,106 29,805 2.17 7295 302 83 267 46 254 0 0 0 0 952
Total 1 15,957 640 8.12 59 0 2 NA 0 0 0 NA NA 0 2
2 301,191 4189 2.87 1317 103 50 NA 0 9 0 NA NA 0 162
3 982,921 30,235 6.13 5318 105 83 359 105 137 0 NA NA 0 789
4 553,786 12,396 4.01 1292 84 0 61 0 20 0 NA 1 0 166
5 1,698,062 78,616 7.95 6927 329 0 190 1 374 0 1 0 2 897
Total 3,551,917 126,076 3.55 14,913 621 135 610 106 540 0 1 1 2 2016
ILI influenza-like illness, NA not available
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hospitals, the total monitored outpatients numbers were
2,178,811 and 1,373,106, ILI were 96,271 and 29,805,
and ILI% were 4.42 and 2.17%, respectively (Table 1).
The results of ANOVA showed that the d1, d2 and d3
were significantly different among the five surveillance
stages (P < 0.001). The results of multiple comparisons by
LSD method showed a significant difference in the num-
ber of outpatients monitored weekly between hospital A
and B between any two stages except between stage 1 and
3. The weekly ILI in hospital A during stage 4 and 5 were
shown to be statistically significant compared to hospital
B, but no statistical significance during the stages from 1
to 3. The weekly numbers of ILI% in hospital A were
shown significance to hospital B during almost all stages
except between stage 3 and 4 (Table 2). These results indi-
cated that HIS could improve the efficiency of ISS system
in monitoring ILI and ILI% significantly (Fig. 3).
The seasonality of ILI in hospital A matched the activity
of influenza virus better than hospital B after the use of
HIS (Fig. 4). Two ILI peaks were almost recorded in each
year from the ISS system during stages 4 and 5 in hospital
A. One peak was recorded in the alternation of winter to
spring, and the other one was in summer (Fig. 4). How-
ever, the seasonality of ILI was not shown in hospital B.
Because of the HIS, the proportion of tested sample des-
cended in hospital A. However, the proportion of positive
Table 2 Multiple comparisons of surveilled patients, ILI and ILI%
among different stages between two sentinel hospitals based
on Least Significant Difference method
Dependent
variables
Stages (I) Stages (J) Mean difference
(I-J)
P
Surveilled patients Stage 1 Stage 2 548.7(a) 0.006
Stage 3 −83.6 0.667
Stage 4 − 2856.6(a) < 0.001
Stage 5 − 3583.7(a) < 0.001
Stage 2 Stage 1 − 548.7(a) 0.006
Stage 3 − 632.3(a) < 0.001
Stage 4 − 3405.3(a) < 0.001
Stage 5 − 4132.4(a) < 0.001
Stage 3 Stage 1 83.66 0.667
Stage 2 632.3(a) < 0.001
Stage 4 − 2773.0(a) < 0.001
Stage 5 − 3500.1(a) < 0.001
Stage 4 Stage 1 2856.6(a) < 0.001
Stage 2 3405.3(a) < 0.001
Stage 3 2773.0(a) < 0.001
Stage 5 − 727.1(a) < 0.001
Stage 5 Stage 1 3583.7(a) < 0.001
Stage 2 4132.4(a) < 0.001
Stage 3 3500.1(a) < 0.001
Stage 4 727.1(a) < 0.001
ILI Stage 1 Stage 2 −19.0 0.557
Stage 3 −38.2 0.222
Stage 4 −126.4(a) < 0.001
Stage 5 − 334.6(a) < 0.001
Stage 2 Stage 1 19.0 0.557
Stage 3 −19.3 0.156
Stage 4 − 107.4(a) < 0.001
Stage 5 − 315.7(a) < 0.001
Stage 3 Stage 1 38.2 0.222
Stage 2 19.3 0.156
Stage 4 −88.1(a) < 0.001
Stage 5 − 296.4(a) < 0.001
Stage 4 Stage 1 126.4(a) < 0.001
Stage 2 107.4(a) < 0.001
Stage 3 88.1(a) < 0.001
Stage 5 −208.3(a) < 0.001
Stage 5 Stage 1 334.6(a) < 0.001
Stage 2 315.7(a) < 0.001
Stage 3 296.4(a) < 0.001
Stage 4 208.3(a) < 0.001
ILI% Stage 1 Stage 2 −5.3(a) < 0.001
Stage 3 −5.9(a) < 0.001
Table 2 Multiple comparisons of surveilled patients, ILI and ILI%
among different stages between two sentinel hospitals based
on Least Significant Difference method (Continued)
Dependent
variables
Stages (I) Stages (J) Mean difference
(I-J)
P
Stage 4 −6.1(a) < 0.001
Stage 5 −8.4(a) < 0.001
Stage 2 Stage 1 5.3(a) < 0.001
Stage 3 −0.6(a) 0.029
Stage 4 −0.8(a) 0.018
Stage 5 −3.1(a) < 0.001
Stage 3 Stage 1 5.9(a) < 0.001
Stage 2 0.6(a) 0.029
Stage 4 −0.2 0.452
Stage 5 −2.5(a) < 0.001
Stage 4 Stage 1 6.1(a) < 0.001
Stage 2 0.8(a) 0.018
Stage 3 0.2 0.452
Stage 5 −2.3(a) < 0.001
Stage 5 Stage 1 8.4(a) < 0.001
Stage 2 3.1(a) < 0.001
Stage 3 2.5(a) < 0.001
Stage 4 2.3(a) < 0.001
a The mean difference is significant at the 0.05 level. ILI, influenza-like illness
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samples almost had same tendency in the two hospitals
(Fig. 5). The inpatient cases on pneumonia ascended after
“HIS (stage 1)” in hospital A (Fig. 6).
There was a total of 14,913 throat swabs collected from
the two hospitals during the five surveillance stages,
among which 2016 were tested positive to influenza or
avian influenza virus. Among the positive results, there
were 621 with H3N2, 135 with H1N1 (seasonal influenza
virus), 610 with H1N1pdm (influenza A / H1N1 from
2009), 106 with untyped influenza A, 540 with B, 1 with
H5N6, 1 with H7N9, and 2 with H9N2 virus. The num-
bers of influenza virus from the two hospitals were similar
during the five stages. However, the outcomes of monitor-
ing avian influenza virus were different between the two
hospitals. In stage 4, one mild H7N9 case was captured in
hospital A when the HIS was adopted at HIS (stage 1). In
stage 5, one mild H5N6 case and two mild H7N9 cases
were captured in hospital A when the HIS was adopted at
HIS (stage 2) (Table 1).
Pneumonia surveillance system
From March, 2009 to September, 2016, there were 5,
491,560 inpatients monitored by the PSS system and
362,743 pneumonia cases, with the rate of 6.61%.
About 10.55% (38,260/362,743) of the cases reported
on pneumonia were severe or death cases. The inci-
dence of pneumonia increased each year in Changsha
(Fig. 6). The seasonality of pneumonia was observed
in spring (Fig. 6a).
We collected 3401 throat swab or lower respiratory
tract samples, among which 2094 were tested positive to
influenza or avian influenza virus. Among the positive
results, 78 were H3N2, 17 were seasonal H1N1, 1871
Fig. 3 Temporal distributions of weekly monitored outpatients, ILI and ILI% of two sentinel hospitals in Changsha City form week 39, 2005 to
week 41, 2016. a, temporal distributions of weekly monitored outpatients; b, temporal distributions of weekly ILI; c, temporal distributions of
weekly ILI%
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were H1N1pdm, 103 were untyped influenza A, 16 were
B, 1 was H5N6, and 8 were H7N9 virus. The activity of
H7N9 virus and that of seasonal viruses especially
H1N1pdm were observed in 2014 (Table 3).
Emerging avian influenza cases
There were 15 avian influenza cases reported from Janu-
ary, 2005 to September, 2016 (Table 4). Four cases were
mild ones that were detected by the ISS system. Nine
cases were severe or death cases that were detected by
the PSS system. Two H5N1 severe cases were missed by
both systems in January, 2009 when the PSS system was
not available. Two H5N6 cases, of which one was mild
case reported by the ISS system in 2014 and the other
was severe case reported by the PSS system in 2016,
were detected in Changsha. Nine H7N9 cases were re-
ported by the two systems. One of them was mild case
and was detected by the ISS system in 2013 and the
other eight were severe / death cases detected by the
PSS system in 2014. Two H9N2 cases were mild cases
and were detected by the PSS system in 2016.
Discussion
The avian influenza viruses have spread to many coun-
tries including China, Thailand [26], Vietnam [27],
Cambodia [28], Turkey [8], the Republic of Azerbaijan
[9], Indonesia [29], and Egypt [10, 30]. To control the
transmission of the disease, surveillance systems with
high sensitivity and specificity need to be created. The
surveillance system is commonly used for monitoring
ILI for detecting avian influenza virus [30]. In Egypt,
clinicians refer all persons with ILI and < 2-week history
of poultry contact to one of the Chest and Fever hospi-
tals throughout the country. The respiratory samples of
ILI cases are collected to test influenza virus. Daily re-
spiratory samples are also collected from 2 ILI cases
and from all patients admitted with severe acute re-
spiratory infection (defined as hospitalization occurring
Fig. 4 Temporal distributions of weekly ILI and weekly number of estimated influenza cases in two sentinel hospitals in Changsha City form week
39, 2005 to week 41, 2016. a temporal distributions of weekly ILI and influenza cases in hospital A; b temporal distributions of weekly ILI and
influenza cases in hospital B. The estimated influenza cases = the number of ILI cases × the proportion of positive samples
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within 2 weeks of onset of fever and cough) in 8 senti-
nel sites [30].
In Changsha City, the ISS and PSS are different with
the surveillance systems in Egypt. The ISS focuses on
detecting mild cases while the PSS focuses on severe or
death cases infected with influenza and emerging avian
influenza viruses (Fig. 2). Therefore, the two systems to-
gether could monitor the viruses with different symp-
toms. The PSS, which covered by all secondary and
tertiary hospitals in the city, is built primarily to monitor
pneumonia cases. Therefore, the PSS could provide us
with the data to estimate the burden of pneumonia and
the pathogen spectrum of pneumonia including influ-
enza and emerging avian influenza viruses.
According to our results, we found that the efficiency
for monitoring ILI and emerging avian influenza virus
was improved after the HIS was used in hospital A. The
differences of ILI were significant between stages 1 to 3
and stages 4 to 5, and between hospital A and hospital B
after the HIS was used. All the mild emerging avian in-
fluenza cases (H5N6, H7N9, H9N2) were detected in the
hospital A where the HIS was adopted. These results
would encourage a higher coverage of the HIS and the
quality of the influenza surveillance in China, to reduce
the repetitive work of doctors and avoid bias from the
manual counting. Moreover, the probability of finding
out influenza and avian influenza virus would be higher
than the existing surveillance system because more ILI
cases would be recorded by HIS.
Because the ISS only focuses on the mild cases or the
early stage of the infection, the surveillance of severe in-
fluenza or avian influenza cases is dependent on the
PSS. The PSS is a system built in Changsha City and
covers all the hospitals that have inpatient departments.
Because the PSS focuses on pneumonia cases instead of
PUE cases, the system might be more sensitive in detect-
ing influenza virus and emerging avian influenza virus.
The PSS has not only given us a way to estimate the dis-
ease burden of pneumonia cases in the city, but also has
played an important role in controlling and preventing
seasonal influenza each year, the pandemic of influenza
A (H1N1) in 2009, and the emerging avian influenza
such as H5N6 and H7N9 by detecting the severe cases
of the infection with these viruses.
Co-infection of seasonal and avian influenza viruses
was commonly observed [31]. However, the co-infection
was not observed by the ISS in our study. But the activ-
ity of H7N9 virus and that of seasonal viruses especially
Fig. 5 Temporal distributions of weekly proportion of tested samples and weekly proportion of positive samples in two sentinel hospitals in
Changsha City, week 39, 2005 to week 41, 2016. a Hospital A; b Hospital B
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Fig. 6 Temporal distributions of pneumonia cases in 49 hospitals and two influenza surveillance sentinel hospitals in Changsha City, March, 2009
to September, 2016. a 49 hospitals; b hospital A; c hospital B
Table 3 Outcomes of pneumonia surveillance system in Changsha City, China
Year Surveilled
patients
Number of
pneumonia
cases
Number of
severe / death
cases
Number
of tested
specimens
Number of positive
H3N2 H1N1 H1N1pdm A (untyped) B H5N1 H5N6 H7N9 H9N2 Total
2009 394,683 27,388 1892 2944 69 17 1794 102 0 0 0 0 0 1982
2010 650,244 30,503 3431 136 1 0 9 1 6 0 0 0 0 17
2011 748,361 34,602 4537 142 0 0 29 0 5 0 0 0 0 34
2012 820,482 39,831 4890 10 3 0 0 0 0 0 0 0 0 3
2013 883,769 47,283 6250 29 0 0 0 0 0 0 0 1 0 1
2014 798,792 62,726 7041 81 5 0 21 0 4 0 0 7 0 37
2015 672,289 67,205 5765 16 0 0 0 0 0 0 0 0 0 0
2016 522,940 53,205 4454 43 0 0 18 0 1 0 1 0 0 20
Total 5,491,560 362,743 38,260 3401 78 17 1871 103 16 0 1 8 0 2094
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H1N1pdm were observed by the PSS in 2014. This dif-
ference might be due to the limited number of reported
avian influenza cases in the PSS.
Limitations
This study has several limitations. Firstly, in the surveil-
lance procedure of the two systems, the tested samples
were not chosen randomly, which might affect the sur-
veillance outcomes and thus might impact our findings.
Secondly, although the two systems have run stably for a
long time and covered a large population, the number of
avian influenza cases was limited. It still needs a longer
time and a larger population to assess the sensitivity and
specificity of the systems. In addition, the ISS system
only covers two sentinel hospitals, and the coverage of
the system should be improved. The missing PSS data in
hospital B from late 2015 to 2016 might underestimate
the ability of the PSS system in detecting the viruses.
Limited by the small number of reported avian influenza
cases in PSS, the co-infection of seasonal and avian in-
fluenza viruses might not be observed apparently. Our
findings also showed that the number of severe pneumo-
nia cases decreased significantly in late 2014 in Hospital
A (Fig. 6). The reason for the decrease remains unclear,
but the decrease might slightly affect the results of de-
tecting influenza cases.
Conclusions
The HIS seems to be able to improve the efficiency of
the ISS for monitoring ILI and emerging avian influenza
virus. Although the PSS could monitor some emerging
avian influenza viruses, the efficiency of the system
needs to be verified in a wider area and in a longer time
span in China.
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Table 4 Avian influenza cases detected by different ways in Changsha City, China
Avian influenza virus Category of cases Detected by ISS system Detected by PSS system Other ways Total
H5N1 Mild cases 0 0 0 0
Severe / death cases 0 0 2 2
H5N6 Mild cases 1 0 0 1
Severe / death cases 0 1 0 1
H7N9 Mild cases 1 0 0 1
Severe / death cases 0 8 0 8
H9N2 Mild cases 2 0 0 2
Severe / death cases 0 0 0 0
Total Mild cases 4 0 0 4
Severe / death cases 0 9 2 11
ISS influenza surveillance system, PSS pneumonia surveillance system
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